ALK and non-small cell lung carcinoma: ODxTT is an NGS‐based test that investigates 46 gene alterations and is also available as companion diagnosis of four gene alterations (EGFR, ALK, ROS1, BRAF) in NSCLC in Japan.This comprehensive analysis consumes only a certain amount of sample tissue, in contrast to multiple single‐gene testing.